MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 36 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,420 | +131300.0% | 27,000 | +53.4% | 0.00% | – |
| Q1 2023 | $30 | -28.6% | 17,601 | -50.8% | 0.00% | – |
| Q4 2022 | $42 | -100.0% | 35,809 | -68.8% | 0.00% | – |
| Q3 2022 | $292,000 | +165.5% | 114,656 | +360.2% | 0.00% | – |
| Q1 2022 | $110,000 | -39.6% | 24,916 | -25.1% | 0.00% | – |
| Q4 2021 | $182,000 | -16.5% | 33,258 | +9.9% | 0.00% | – |
| Q3 2021 | $218,000 | – | 30,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |